Both in Pharmaceuticals
Acadia Pharmaceuticals vs Organon &
Over the past year ACAD returned −5.5% and OGN returned +106.4%; their daily moves had a correlation of 0.02.
ACAD −5.5% OGN +106.4%Growth of $1, one year, split-adjusted
| Metric | ACAD | OGN |
|---|---|---|
| Price | $21.14 | $13.85 |
| Market cap | $3.64B | $3.64B |
| Today | +2.75% | 0.00% |
| 1 month | +7.1% | +0.8% |
| 6 months | −1.6% | +3.3% |
| Year to date | −20.9% | +93.2% |
| 1 year | −5.5% | +106.4% |
| Revenue growth (YoY) | +16.4% | −1.7% |
| Gross margin | 90.8% | 55.2% |
| Net margin | 10.2% | 10.4% |
| P/E (TTM) | 9.6× | 17.1× |
| Price / sales | 3.2× | 0.6× |
| Net cash | $956.5M | -$7.10B |
| Dividend yield | — | 0.58% |
| Volatility (60d) | 44.3% | 2.9% |
| Short % of float | 7.1% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).